The present study was performed to investigate the Hepatoprotective potential of the Biofield Energy (The Trivedi Effect®) Treated test item, Dulbecco’s Modified Eagle Medium (DMEM) in HepG2 cells. The test item was distributed into two parts. One part received Consciousness Energy Healing Treatment by a renowned Biofield Energy Healer, Mahendra Kumar Trivedi and was labeled as the Biofield Energy Treated DMEM group and the other part referred as the untreated DMEM group, where no Biofield Treatment was provided. Results showed that more than 97% cell viability of the test items were observed by MTT assay, which indicated a safe and nontoxic nature of the test items. The Biofield Treated DMEM showed significant (p≤0.001) protection of cells by 10% against oxidative stress induced by t-BHP, while the untreated DMEM group showed 0.4% protection. The level of interleukin-8 (IL-8) was significantly (p≤0.01) reduced by 31.57% in Biofield Treated DMEM than untreated DMEM. The level of ALT enzyme activity was significantly (p≤0.001) reduced by 66% in Biofield Treated DMEM compared to untreated DMEM. Cholesterol level was significantly (p≤0.001) reduced by 46.23% in Biofield Treated DMEM than untreated DMEM. Besides, Biofield Treated DMEM group showed 51.18% increased the level of albumin compared to untreated DMEM group. Overall, results demonstrated that Biofield Treatment significantly protect the liver hepatocytes against oxidative stress. Therefore, Consciousness Energy Healing (The Trivedi Effect®) Treatment might be useful as a hepatoprotectant against different types of liver injuries like cirrhosis, alcohol abuse, hemochromatosis, Wilson’s disease, Gilbert’s disease, cholangiocarcinoma, steatosis, Budd-Chiari syndrome, etc.
1. Shah VN, Shah MB, Bhatt PA (2011) Hepatoprotective activity of pu-narnavashtak kwath, an Ayurvedic formulation, against CCl4-induced hepatotoxicity in rats and on the HepG2 cell line. Pharm Biol 49: 408-415.
2. Ge PS, Runyon BA (2016) Treatment of patients with cirrhosis. N Engl J Med 375: 767-777.
3. Praneetha P, Durgaiah G, Y NR, Kumar B R (2017) In vitro hepato-protective effect of Echinochloa colona on ethanol-induced oxidative damage in HepG2 cells. Asian J Pharm Clin Res 10: 259-261.
4. Contreras-Zentella ML, Hernández-Muñoz R (2016) Is liver enzyme release really associated with cell necrosis induced by oxidant stress? Oxid Med Cell Longev 2016: 3529149.
5. Schmidt E, Schmidt FW (1970) Aspects of enzyme diagnosis. Med Welt 21: 805-816.
6. Frederiks WM, Vogels IM, Fronik GM (1984) Plasma ornithine car-bamyl transferase level as an indicator of ischaemic injury of rat liver. Cell Biochem Funct 2: 217-220.
7. Jessen BA, Mullins JS, de Peyster A, Stevens GJ (2003) Assessment of hepatocytes and liver slices as in vitro test systems to predict in vivo gene expression. Toxicol Sci 75: 208-222.
8. Duthie SJ, Melvin WT, Burke MD (1994) Bromobenzene detoxification in the human liver-derived HepG2 cell line. Xenobiotica 24: 265-279.
9. Sassa S, Sugita O, Galbraith RA, Kappas A (1987) Drug metabolism by the human hepatoma cell, HepG2. Biochem Biophys Res Commun 143: 52-57.
10. Ironson G, Field T, Scafidi F, Hashimoto M, Kumar M, et al. (1996) Massage therapy is associated with enhancement of the immune sys-tem’s cytotoxic capacity. Int J Neurosci 84: 205-217.
11. Lutgendorf SK, Mullen-Houser E, Russell D, Degeest K, Jacobson G, et al. (2010) Preservation of immune function in cervical cancer pa-tients during chemoradiation using a novel integrative approach. Brain Behav Immun 24: 1231-1240.
12. Jain S, Hammerschlag R, Mills P, Cohen L, Krieger R, et al. (2015) Clinical studies of Biofield therapies: Summary, methodological chal-lenges, and recommendations. Glob Adv Health Med 4: 58-66.
13. Rubik B (2002) The Biofield hypothesis: Its biophysical basis and role in medicine. J Altern Complement Med 8: 703-717.
14. Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) The po-tential impact of biofield treatment on human brain tumor cells: A time-lapse video microscopy. J Integr Oncol 4: 141.
15. Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) In vitro evaluation of Biofield treatment on cancer biomarkers involved in en-dometrial and prostate cancer cell lines. J Cancer Sci Ther 7: 253-257.
16. Trivedi MK, Branton A, Trivedi D, Nayak G, Plikerd WD, et al. (2017) A Systematic study of the biofield energy healing treatment on physico-chemical, thermal, structural, and behavioral properties of magnesium gluconate. International Journal of Bioorganic Chemistry 2: 135-145.
17. Parulkar VR, Trivedi MK, Branton A, Trivedi D, Nayak G, et al. (2018) Improved metabolism of vitamin d3 in human osteoblasts cells after biofield energy healing treatment. American Journal of Laboratory Medicine. 3: 11-19.
18. Parulkar VR, Trivedi MK, Branton A, Trivedi D, Nayak G, et al. (2017) The use of consciousness energy healing based herbomineral formu-lation for skin anti-aging strategies. Journal of Food and Nutrition Sci-ences 5: 96-106.
19. Singh J, Trivedi MK, Branton A, Trivedi D, Nayak G, et al. (2017) Con-sciousness energy healing treatment based herbomineral formulation: A safe and effective approach for skin health. American Journal of Pharmacology and Phytotherapy 2: 1-10.
20. Anagnos D, Trivedi K, Branton A, Trivedi D, Nayak G, et al. (2018) Influence of Biofield treated vitamin D3 on proliferation, differentia-tion, and maturation of bone-related parameters in MG-63 cell-line. International Journal of Biomedical Engineering and Clinical Science 4: 6-14.
21. Lee AC, Trivedi K, Branton A, Trivedi D, Nayak G, et al. (2018) The potential benefits of Biofield energy treated vitamin D3 on bone min-eralization in human bone osteosarcoma cells (MG-63). International Journal of Nutrition and Food Sciences 7: 30-38.
22. Stutheit ME, Trivedi K, Branton A, Trivedi D, Nayak G, et al. (2018) Biofield energy treated vitamin D3: Therapeutic implication on bone health using osteoblasts cells. American Journal of Life Sciences 6: 13-21.
23. Trivedi MK, Tallapragada RM (2008) A transcendental to changing metal powder characteristics. Met Powder Rep 63: 22-28, 31.
24. Trivedi MK, Nayak G, Patil S, Tallapragada RM, Latiyal O (2015) Stud-ies of the atomic and crystalline characteristics of ceramic oxide nano powders after bio field treatment. Ind Eng Manage 4: 161.
25. Trivedi MK, Nayak G, Patil S, Tallapragada RM, Latiyal O, et al. (2015) Effect of Biofield energy treatment on physical and structural proper-ties of calcium carbide and praseodymium oxide. International Journal of Materials Science and Applications 4: 390-395.
26. Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, et al. (2015) Morphological characterization, quality, yield and DNA fingerprinting of biofield energy treated alphonso mango (Mangifera indica L.). Journal of Food and Nutrition Sciences 3: 245-250.
27. Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, et al. (2015) Evaluation of biochemical marker - Glutathione and DNA fingerprinting of biofield energy treated Oryza sativa. American Journal of BioSci-ence 3: 243-248.
28. Trivedi MK, Branton A, Trivedi D, Nayak G, Charan S, et al. (2015) Phenotyping and 16S rDNA analysis after biofield treatment on Cit-robacter braakii: A urinary pathogen. J Clin Med Genom 3: 129.
29. Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) Evaluation of biofield modality on viral load of Hepatitis B and C viruses. J Antivir Antiretrovir 7: 83-88.
30. Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) An impact of biofield treatment: Antimycobacterial susceptibility potential using BACTEC 460/MGIT-TB System. Mycobact Dis 5: 189.
31. Trivedi MK, Patil S, Shettigar H, Bairwa K, Jana S (2015) Phenotypic and biotypic characterization of Klebsiella oxytoca : An impact of Bio-field treatment. J Microb Biochem Technol 7: 203-206.
32. Nayak G, Altekar N (2015) Effect of biofield treatment on plant growth and adaptation. J Environ Health Sci 1: 1-9.
33. Branton A, Jana S (2017) The influence of energy of consciousness healing treatment on low bioavailable resveratrol in male Sprague Dawley rats. International Journal of Clinical and Developmental Anat-omy 3: 9-15.
34. Branton A, Jana S (2017) The use of novel and unique biofield energy healing treatment for the improvement of poorly bioavailable com-pound, berberine in male Sprague Dawley rats. American Journal of Clinical and Experimental Medicine 5: 138-144.
35. Branton A, Jana S (2017) Effect of The biofield energy healing treat-ment on the pharmacokinetics of 25-hydroxyvitamin D3 [25(OH)D3] in rats after a single oral dose of vitamin D3. American Journal of Phar-macology and Phytotherapy 2: 11-18.
36. Yen GC, Yeh CT, Chen YJ (2004) Protective effect of Mesona procum-bens against tert-butyl hydroperoxide-induced acute hepatic damage in rats. J Agric Food Chem 52 (13): 4121-4127.
37. Ali MY, Jannat S, Jung HA, Min BS, Paudel P, et al. (2018) Hepato-protective effect of Cassia obtusifolia seed extract and constituents against oxidative damage induced by tert-butyl hydroperoxide in hu-man hepatic HepG2 cells. J Food Biochem 42: e12439.
38. Baggiolini M, Walz A, Kunkel SL (1989) Neutrophil-activating pep-tide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84: 1045-1049.
39. Vlahopoulos S, Boldogh I, Casola A, Brasier AR (1999) Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: Evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 94: 1878-1889.
40. Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, et al. (2011) Interleukin-8 Is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. Bertoletti A, ed. PLoS ONE 6: e21381.
41. Limdi JK, Hyde GM (2003) Evaluation of abnormal liver function tests. Postgrad Med J 79: 307-312.
42. Mathiesen U, Franzen L, Fryden A, Foberg U, Bodemar G (1999) The clinical significance of slightly to moderately increased liver transami-nase values in asymptomatic patients. Scand J Gastroenterol 34: 85-91.
43. Molander DW, Sheppard E, Payne MA (1957) Serum transaminase in liver disease. J Am Med Inform Assoc 163: 1461-1465.
44. Halsted CH (2004) Nutrition and alcoholic liver disease. Semin Liver Dis 24: 289-304.
45. Zhao Q, Li J, Yang J, Li R (2017) Association of total cholesterol and HDL-C levels and outcome in coronary heart disease patients with heart failure. Gilardi. L, ed. Medicine 96: e6094.
46. Quinlan GJ, Martin GS, Evans TW (2005) Albumin: Biochemical prop-erties and therapeutic potential. Hepatology 41: 1211-1219.
47. Evans TW (2002) Review article: Albumin as a drug-biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther 5: 6-11.
48. Quinlan GJ, Margarson MP, Mumby S, Evans TW, Gutteridge JM (1998) Administration of albumin to patients with sepsis syndrome: A possible beneficial role in plasma thiol repletion. Clin Sci (Lond) 95: 459-465.
Cite this work
Researchers should cite this work as follows:
Trivedi MK, Jana S (2018) Hepatoprotective Effect of Biofield Energy Treatment On Tert-Butyl Hydro Peroxide Induced Liver Injury in Hepatocellular Carcinoma Cell Line (HepG2). Biomark Applic BMAP-129. DOI: 10.29011/2576-9588. 100029